HAEMATOLOGY

Haematology Department Clinical Trial Programme

The Christchurch Haematology Service is a tertiary centre for
the South  Island of New Zealand. Services include Bone Marrow transplantation 
(both autologous and allogeneic), treatment for Haematological malignancies,
bleeding and thrombotic disorders.                                        
Supporting specialist laboratory services include surface markers, 
bone marrow processing, cytogenetic, molecular and specialist haemostasis.    
                                                              
The Haematology department is also supported CLICK HERE TO GO TO CURRENT TRIALS
by the research laboratories in cellular and
molecular haematology.                                                                                                                                                                                                                                                                                                   CLICK HERE TO GO TO CLOSED TRIALS

Key Personnel                                                                                Photo of Helen, Jo & Carolyn - Trials Co-ordinators

The Christchurch Haematology Clinical Trials Programme functions within the Christchurch Haematology Service at the Canterbury District Health Board and consists of 6 Haematologists. Three senior research coordinators lead the trial programme with all haematologists taking responsibility for clinical research within their area of expertise.

Aims and Objectives

The primary objective of the Haematology clinical trials programme is to improve the standards of care offered to our patients by participating in well designed clinical trials which can offer access to innovative treatments. 

Professional Associations

Local and International
Australasian Leukaemia and Lymphoma Group (ALLG)
New Zealand Leukaemia Study Group (NZLSG)
New Zealand Bone Marrow transplant Study Group (NZBMTSG)
Centre for International Blood and Bone Marrow Transplant research (CIBMTR)
European Group for Bone marrow transplantation (EBMT)
Australasian Bone Marrow Transplant Recipient registry (ABMTRR)
French Lymphoma Group (GELA)
National Cancer Research Institute (NCRI)
UK Medical Research Council (UK MRC)
Cancer Research UK (MRCCTU)

The Clinical Trial Programme has been supported by:

Amgen          Maxim                         Wyeth
Aventis         Merck Sharp & Dohme    Sanofi Sythelaba
Bayer            Norvartis                     Genta 
Genentech     Roche